GET DAILY SIGNALSChronoScale Holdings Corporation (CHRN): Analyst Target of $28.50 Points to +145% Upside
Key Takeaways
- The central stock price target of $28.50 is the arithmetic mean of the two verified, current analyst price targets for ChronoScale Holdings Corporation (CHRN).
- With the stock near $11.62, reaching $28.50 would require a gain of roughly 145%, a very large move by any standard.
- The analyst range is wide in dollar terms but consistent in direction: $25 from Compass Point (October 16, 2026) to $32 from Northland Securities (initiated September 18, 2026, reiterated October 2, 2026).
- Supporting factors include exposure to fast-growing demand for AI-focused compute infrastructure and the backing of parent company Applied Digital Corporation.
- The biggest risks are persistent losses, ongoing cash burn, a thin analyst base, and a share price still well below its 52-week high near $30.
- Get more information about CHRN's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
- Explore Trending AI Robots to see AI-driven trading strategies across the market.
Analyst Price Targets and Consensus View
ChronoScale Holdings Corporation is a Dallas, Texas-based developer of a compute platform purpose-built for artificial intelligence (AI) workloads, providing dedicated GPU-accelerated cloud infrastructure. It operates as a subsidiary of Applied Digital Corporation and was renamed from ChronoScale Corporation in July 2026.
Because the company is newly public, analyst coverage is thin. Two current, attributable targets form the basis of this analysis. Northland Securities analyst Nehal Chokshi initiated coverage with an Outperform rating and a $32 price target in mid-September 2026 and reiterated that Buy-equivalent view in early October. Compass Point initiated coverage with a Buy rating and a $25 target on October 16, 2026. Averaging those two figures yields $28.50, the central target used throughout this article. Some aggregators also carry older pre-2026 figures (including a stale lower target), which are excluded here as outdated. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Both current analysts are constructive, but their targets still span $25 to $32, a roughly 28% gap, reflecting genuine uncertainty about how quickly the company can convert AI demand into profitable revenue.
Current Market Position and Path Toward the Target
The shares last traded around $11.62, giving the company a market capitalization of roughly $1.69 billion. Reaching $28.50 would therefore require an advance of about 145% — a very large move. The stock is also down roughly 60% from its 52-week high of $30, having traded as low as $3.50 over the past year.
The path to the target would depend on a meaningful re-rating of the business. Revenue over the trailing twelve months is approximately $96 million, but the company remains deeply unprofitable, with negative EPS (earnings per share) and a price-to-sales ratio near 17x. That is a demanding valuation for a loss-making, early-stage operator, meaning the shares would need sustained evidence of revenue acceleration and improving unit economics to support a move of this magnitude.
What Could Support a Move Toward the Target
- AI infrastructure demand. The company sits directly in a high-growth segment — dedicated compute environments for AI and machine learning developers.
- Parent-company backing. Its relationship with Applied Digital Corporation provides operational and strategic support, though it also creates concentration risk.
- Revenue momentum. Any acceleration in large-scale deployment contracts, customer wins, or GPU capacity utilization could shift sentiment quickly for a small-cap AI name.
- Analyst sentiment. Both initiating firms issued bullish ratings, and additional initiations or target increases could narrow the valuation discount.
What Could Prevent the Target From Being Reached
- Persistent losses. Negative earnings and ongoing cash burn leave the company dependent on external capital and the parent's support.
- Rich valuation. A price-to-sales multiple near 17x on roughly $96 million of revenue leaves little room for execution missteps.
- Thin coverage and volatility. With only two current analysts, the stock is susceptible to sharp moves on limited news flow; beta is about 1.10.
- Drawdown risk. The shares remain far below their $30 high, indicating investors have already repriced some of the initial enthusiasm.
Technical Levels and Market Structure
The most durable reference points are the 52-week extremes. The $30 area, near the prior high, is the primary resistance level and sits just above the $28.50 target — meaning the target itself is anchored near a meaningful overhead zone. On the downside, the stock recently found footing in the low-to-mid $10s after a multi-month slide, a zone that now serves as near-term support. A sustained close back above roughly $15–$16 would mark an early step toward repairing the longer-term downtrend. From what I see, tracking these levels with tools like Tickeron’s AI Trend Prediction Engine helps clarify the setup.
Time Horizon and What Investors Should Monitor
Analyst price targets typically reflect a roughly 12-month research horizon, though the exact horizon is not disclosed for either initiating report. Investors should watch quarterly results, guidance, and any commentary on GPU capacity deployments, customer contracts, and the company's relationship with Applied Digital. Given the cash-burn profile, balance-sheet updates and any capital-raising activity are equally important. Broad AI-sector sentiment and interest-rate expectations, which influence how richly unprofitable growth companies are valued, also matter.
Using AI Daily Buy/Sell Signals for CHRN
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly covered name like CHRN, this kind of automated monitoring can help traders discover opportunities, track positions, and spot shifting trends more efficiently than manual screening. Traders interested in a systematic view of daily momentum may find these signals a useful complement to traditional research.
Final Assessment
The question of whether ChronoScale Holdings can reach $28.50 hinges on an unusually large — roughly 145% — advance from current levels. The target is the average of two bullish, current analyst views ranging from $25 to $32, and it sits just below the stock's prior high near $30, a natural area of resistance. The bull case rests on AI-compute demand and the Applied Digital relationship; the bear case rests on losses, cash burn, and a demanding valuation. With coverage still thin, investors should watch revenue trajectory, contract announcements, and the balance sheet rather than treating the $28.50 figure as a forecast. No outcome is guaranteed, and the target reflects analyst expectations, not a prediction.
Exploring Tickeron AI Tools for Deeper Research
In my own work on names like this, I often turn to Tickeron’s suite of AI tools to cross-check analyst views and technical setups. The platform’s pattern recognition and signal generation features provide an additional layer of data that complements traditional coverage, especially for early-stage companies with limited Wall Street attention. It is not a replacement for fundamental analysis, but it has become a regular part of how I review opportunities in the AI infrastructure space.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CHRN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 04, 2026
CHRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 39 of 40 cases where CHRN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CHRN's RSI Indicator exited the oversold zone, 29 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +14.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRN advanced for three days, in 239 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHRN as a result. In 69 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for CHRN turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 40 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for CHRN entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. CHRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.026) is normal, around the industry mean (2.898). P/E Ratio (0.000) is within average values for comparable stocks, (18.492). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.224) among similar stocks. P/S Ratio (36.101) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InformationTechnologyServices
Advertisement